Collins L, Seraj S Diagnosis and treatment of venous ulcers. Am Fam Physician. 2010 Apr 15;81(8):989-96.
Evison D, Brown RF, Rice P The treatment of sulphur mustard burns with laser debridement. J Plast Reconstr Aesthet Surg. 2006;59(10):1087-93. Epub 2006 Jul 7.
Falanga V Chronic wounds: pathophysiologic and experimental considerations. J Invest Dermatol. 1993 May;100(5):721-5. Review.
Lam DG, Rice P, Brown RF The treatment of Lewisite burns with laser debridement---'lasablation'. Burns. 2002 Feb;28(1):19-25.
Palfreyman S Assessing the impact of venous ulceration on quality of life. Nurs Times. 2008 Oct 14-20;104(41):34-7.
Percival SL, Francolini I, Donelli G Low-level laser therapy as an antimicrobial and antibiofilm technology and its relevance to wound healing. Future Microbiol. 2015;10(2):255-72. doi: 10.2217/fmb.14.109. Review.
Pozner JN, Goldberg DJ Superficial erbium:YAG laser resurfacing of photodamaged skin. J Cosmet Laser Ther. 2006 Jun;8(2):89-91.
Roberts TL 3rd, Pozner JN Lasers, facelifting, and the future. Clin Plast Surg. 2000 Apr;27(2):293-9.
Stellar S, Meijer R, Walia S, Mamoun S Carbon dioxide laser debridement of decubitus ulcers: followed by immediate rotation flap or skin graft closure. Ann Surg. 1974 Feb;179(2):230-7.
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
